CYP4F2 genetic variant alters required warfarin dose (Q34746151)

4 August 2017

CYP4F2 genetic variant alters required warfarin dose (English)

1 reference

4 August 2017

1 reference

8

Yaron Turpaz

1 reference

4 August 2017

Michael D Caldwell

1

1 reference

4 August 2017

Tarif Awad

2

1 reference

4 August 2017

Julie A Johnson

3

1 reference

4 August 2017

Brian F Gage

4

1 reference

4 August 2017

Mat Falkowski

5

1 reference

4 August 2017

Paul Gardina

6

1 reference

4 August 2017

Jason Hubbard

7

1 reference

4 August 2017

Taimour Y Langaee

9

1 reference

4 August 2017

Charles Eby

10

1 reference

4 August 2017

Cristi R King

11

1 reference

4 August 2017

Amy Brower

12

1 reference

4 August 2017

John R Schmelzer

13

1 reference

4 August 2017

Ingrid Glurich

14

1 reference

4 August 2017

Humberto J Vidaillet

15

1 reference

4 August 2017

Steven H Yale

16

1 reference

4 August 2017

Kai Qi Zhang

17

1 reference

4 August 2017

Richard L Berg

18

1 reference

4 August 2017

James K Burmester

19

1 reference

4 August 2017

language of work or name

English

0 references

publication date

4 February 2008

1 reference

4 August 2017

1 reference

4 August 2017

111

1 reference

4 August 2017

4106-4112

1 reference

4 August 2017

8

1 reference

CYP2C9 genotype-guided warfarin prescribing enhances the efficacy and safety of anticoagulation: a prospective randomized controlled study.

4 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288721

Replicating genotype-phenotype associations

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288721

Multiplex assay for comprehensive genotyping of genes involved in drug metabolism, excretion, and transport

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288721

Identifying the genotype behind the phenotype: a role model found in VKORC1 and its association with warfarin dosing

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288721

Evaluation of genetic factors for warfarin dose prediction

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288721

Genetic-based dosing in orthopedic patients beginning warfarin therapy.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288721

Functional polymorphism in human CYP4F2 decreases 20-HETE production

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288721

Comprehensive assessment of metabolic enzyme and transporter genes using the Affymetrix Targeted Genotyping System

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288721

Pharmacogenetics-based coumarin therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288721

A prospective, randomized pilot trial of model-based warfarin dose initiation using CYP2C9 genotype and clinical data

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288721

Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288721

Common VKORC1 and GGCX polymorphisms associated with warfarin dose

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288721

Highly multiplexed molecular inversion probe genotyping: over 10,000 targeted SNPs genotyped in a single tube assay

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288721

Haploview: analysis and visualization of LD and haplotype maps

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288721

The International HapMap Project

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288721

Multiplexed genotyping with sequence-tagged molecular inversion probes

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288721

Gene-based SNP discovery as part of the Japanese Millennium Genome Project: identification of 190,562 genetic variations in the human genome. Single-nucleotide polymorphism

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288721

The morbidity related to atrial fibrillation at a tertiary centre in one year: 9.0% of all strokes are potentially preventable

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288721

Frequency of major complications of aspirin, warfarin, and intravenous heparin for secondary stroke prevention. A population-based study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288721

Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288721

Bleeding complications in oral anticoagulant therapy. An analysis of risk factors.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288721

Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288721

Influence of coagulation factor, vitamin K epoxide reductase complex subunit 1, and cytochrome P450 2C9 gene polymorphisms on warfarin dose requirements.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288721

Prospective dosing of warfarin based on cytochrome P-450 2C9 genotype.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288721

A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288721

Relative impact of covariates in prescribing warfarin according to CYP2C9 genotype

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288721

CYP2C9 genotypes and dose requirements during the induction phase of oral anticoagulant therapy

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288721

Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarin.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288721

Cytochrome P450 omega-hydroxylase pathway of tocopherol catabolism. Novel mechanism of regulation of vitamin E status

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288721

Optimal oral anticoagulant therapy in patients with mechanical heart valves.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288721

A high-throughput SNP typing system for genome-wide association studies

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288721

Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications

26 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18250228

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18250228

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Estimation of warfarin maintenance dose based on VKORC1 (-1639 G>A) and CYP2C9 genotypes

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18250228

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1182/BLOOD-2007-11-122010

1 reference

4 August 2017

1 reference

4 August 2017

1 reference